NDC 36987-2865
Red Oak
Red Oak
Red Oak is a Intradermal; Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Nelco Laboratories, Inc.. The primary component is Quercus Rubra Pollen.
| Product ID | 36987-2865_2a72f629-5585-48e0-bd3f-7804035e57fb |
| NDC | 36987-2865 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Red Oak |
| Generic Name | Red Oak |
| Dosage Form | Injection, Solution |
| Route of Administration | INTRADERMAL; SUBCUTANEOUS |
| Marketing Start Date | 1972-08-29 |
| Marketing Category | BLA / BLA |
| Application Number | BLA102192 |
| Labeler Name | Nelco Laboratories, Inc. |
| Substance Name | QUERCUS RUBRA POLLEN |
| Active Ingredient Strength | 40000 [PNU]/mL |
| Pharm Classes | Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [CS],Allergens [CS] |
| NDC Exclude Flag | E |
| Listing Certified Through | 2017-12-31 |
Packaging
NDC 36987-2865-2
10 mL in 1 VIAL, MULTI-DOSE (36987-2865-2)
| Marketing Start Date | 1972-08-29 |
| NDC Exclude Flag | N |
| Sample Package? | N |
NDC SPL Data Element Entries
NDC 36987-2865-4 [36987286504]
Red Oak INJECTION, SOLUTION
| Marketing Category | BLA |
| Application Number | BLA102192 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1972-08-29 |
| Inactivation Date | 2019-10-21 |
NDC 36987-2865-3 [36987286503]
Red Oak INJECTION, SOLUTION
| Marketing Category | BLA |
| Application Number | BLA102192 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1972-08-29 |
| Inactivation Date | 2019-10-21 |
NDC 36987-2865-2 [36987286502]
Red Oak INJECTION, SOLUTION
| Marketing Category | BLA |
| Application Number | BLA102192 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1972-08-29 |
| Inactivation Date | 2019-10-21 |
NDC 36987-2865-1 [36987286501]
Red Oak INJECTION, SOLUTION
| Marketing Category | BLA |
| Application Number | BLA102192 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1972-08-29 |
| Inactivation Date | 2019-10-21 |
Drug Details
Active Ingredients
| Ingredient | Strength |
|---|---|
| QUERCUS RUBRA POLLEN | 40000 [PNU]/mL |
OpenFDA Data
Pharmacological Class
- Non-Standardized Pollen Allergenic Extract [EPC]
- Increased Histamine Release [PE]
- Cell-mediated Immunity [PE]
- Increased IgG Production [PE]
- Pollen [CS]
- Allergens [CS]
NDC Crossover Matching brand name "Red Oak" or generic name "Red Oak"
| NDC | Brand Name | Generic Name |
|---|---|---|
| 36987-2861 | Red Oak | Red Oak |
| 36987-2862 | Red Oak | Red Oak |
| 36987-2863 | Red Oak | Red Oak |
| 36987-2864 | Red Oak | Red Oak |
| 36987-2865 | Red Oak | Red Oak |
| 36987-2866 | Red Oak | Red Oak |
| 36987-2867 | Red Oak | Red Oak |
| 36987-2868 | Red Oak | Red Oak |
| 0268-6642 | QUERCUS RUBRA POLLEN | Red Oak |
| 0268-6738 | QUERCUS RUBRA POLLEN | Red Oak |
Trademark Results [Red Oak]
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.